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Abstract: Mycotoxins are toxic secondary metabolites produced by certain filamentous fungi.
The occurrence of mycotoxins in food and feed causes negative health impacts on both humans
and animals. Clay binders, yeast cell walls, or antioxidant additives are the most widely used
products for mycotoxin elimination to reduce their impact. Although conventional methods are
constantly improving, current research trends are looking for innovative solutions. Nanotechnology
approaches seem to be a promising, effective, and low-cost way to minimize the health effects of
mycotoxins. This review aims to shed light on the critical knowledge gap in mycotoxin elimination
by nanotechnology. There are three main strategies: mold inhibition, mycotoxin adsorption,
and reducing the toxic effect via nanoparticles. One of the most promising methods is the use
of carbon-based nanomaterials. Graphene has been shown to have a huge surface and high binding
capacity for mycotoxins. Attention has also been drawn to polymeric nanoparticles; they could
substitute adsorbents or enclose any substance, which would improve the health status of the
organism. In light of these findings, this review gives new insights into possible future research that
might overcome challenges associated with nanotechnology utilization for mycotoxin elimination
from agricultural products.
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1. Introduction
Mycotoxins are produced by molds under specific conditions, such as high humidity, poor
agricultural practices, or damaged and contaminated crops. Although the presence of molds on grains
does not necessarily mean there are mycotoxins present, the potential for mycotoxin production does
exists. Further, the long-term absence of molds on stored food and feed does not guarantee that
the grain is free of mycotoxins [1,2]. The issue of mycotoxin risk is therefore tricky and requires the
attention of both agrotechnology specifically and the scientific community generally.
The main producers of mycotoxins are species of Aspergillus (aflatoxins (AFL), ochratoxin A
(OTA), trichothecenes, and deoxynivalenol (DON)), Fusarium (zearalenone (ZEA), fumonisins (FUM)
B1 and B2, and the emerging mycotoxins fusaproliferin, moniliformin, beauvericin, and enniatins),
Claviceps (ergot alkaloids), and Alternaria (altenuene, alternariol, alternariol methyl ether, altertoxin,
and tenuazonic acid) [3]. These mycotoxins are among the most dangerous. They may cause
cardiotoxicity, central nervous system disorders, gastrointestinal tract damage, nephrotoxicity,
and hepatotoxicity. The mechanisms of mycotoxin toxicity have been studied for many years [4–9].
Currently, there are about 500 species of mycotoxins and it is estimated that another 1000 have yet to
be discovered. Especially, masked mycotoxins pose a great risk because there is no established routine
method for determining them [10].
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Correct crop management practices play an important role in mycotoxin occurrence prevention.
Furthermore, during the growing period, negative impacts on mycotoxin propagation could include
drought, insect attack, temperature fluctuations, or crop rotation [11]. Humidity, grain fragments,
or weeds are the major factors for mold propagation in stored materials [12].
Mycotoxins are known to cause a number of toxic effects in animal species. The most sensitive is
poultry, followed by pigs and ruminants [13]. Generally, it is well known that ruminants metabolize
some kinds of mycotoxins with almost 100% efficacy [14]. Mycotoxins have the ability to become part
of animal products because they are largely lipophilic [15]. For example, AFL M1 easily gets into milk,
which can cause serious health problems [16].
Recent trends in mycotoxin elimination from food and feed have led to the application of
various adsorbents as nutritional additives. The most used are clay particles such as bentonites
and zeolites due to their opposite polarity [17]. The disadvantage of clay absorbers is their ability
to bind to minerals and vitamins from feed. For this reason, the dietary content of micronutrients
have to be increased by an average of 20% [18,19]. Besides, clay adsorbents could be used in yeast
cell walls (Saccharomyces cerevisiae) [20–22]. However, the effectiveness of mycotoxin absorbents
themselves ranges from 20% to 80%. A single assessment of the effectiveness of adsorbents has not yet
been established.
Nevertheless, mycotoxins are an important issue in a number of disciplines such as food
science, toxicology, applied and analytical chemistry, veterinary sciences, mycology, plant science,
and agriculture. This topic has been studied far less from a nanotechnological point of view, although
nanotechnology is a dynamically evolving discipline [23,24]. The key properties in this field of research
are based on the nanoscale. For example, gravity is no longer relevant here as well as the shape
and net charge, which greatly changes the behavior of the material. Nanotechnologies allow for the
alteration of already discovered properties and the creation of endlessly new materials with exciting
possibilities [25]. Nowadays, some of the latest developments in nanotechnology are commercially
used in medicine, the household, textiles, and electrotechnics.
In this review, we focus on the key words mycotoxins, nanotechnology, nanoparticles (NPs),
and agriculture. Recent research suggests that nanotechnology is increasingly penetrating the field of
agriculture and mycotoxins. The first development of nanotechnological applications for mycotoxin
elimination or detection have been implemented since 2009 [26]. Although several studies have already
focused on the use of nanotechnology for mycotoxin elimination, these experimental results have not
yet been reviewed.
2. Mycotoxin Detection Using Nanoparticles
Regarding mycotoxins, many analytical methods have been developed for their reliable
determination. Currently, the most commonly used approaches in practice are high-pressure liquid
chromatography (HPLC) and mass detection and enzyme-linked immunoassay (ELISA) [27,28].
Since early detection is needed to protect health, current research has focused on improving the
detection limit, time consumption, sample consumption, and ease of use [29–32]. Practice distinguishes
two different types of NP utilization in detection systems [33,34]. On the receptor level, NPs directly
react with the detected molecule. This system requires adequate specificity and reproducibility.
NPs could be evolved as a transducer-enhancing signal to the detector. An overview of these
technologies is given by Rai et al. (2015). This work summarizes the possibilities of the immobilization
of biomolecules and states that mycotoxins warrant further research regarding the construction
of nanobiosensors with more stability and durability [33]. In this case, the advantage of NPs
is their high surface-area-to-volume ratio, which enables the binding of higher concentrations of
mycotoxins [35]. Over the past decade, research in nanomaterials has focused on carbon nanotubes,
polymers, superparamagnetic NPs, quantum dots, and metal NPs. In addition, the use of nanoparticles
allows various modifications with the specific ligands or surface decoration by functional groups such
as CH3, −OH, −COOH, −NH2, or −CONH2.
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Much of the current literature on mycotoxin detection pays particular attention to
immunodetection of mycotoxins (Figure 1). Lateral flow immunochromatographic assay is a rapidly
developing technique which combines antibodies (for specificity) and NPs (for sensitivity). Taking
advantage of gold NPs of quantum dots, the limit of detection for various mycotoxins is in the range
of 0.1–10,000 ng/mL [36]. Immunoelectrodes have been designed based on bismuth oxide nanorods
for AFL B1 detection [37] (Figure 1a). The third generation of immunosensors is characterized by
rapid response (15 s), high sensitivity (1.132 µA/(ng/dL)), broad linear range (1–70 ng/dL), and low
detection limit (8.715 ng/dL) and operates by direct electron transfer of analytes to electrodes [38].
Immunochromatographic ready-to-use test strips have recently been proposed for the simultaneous
detection of ZEA and T2 toxin with detection limits of 0.1 and 0.05 ng/mL. Perfect sensitivity and
rapid testing have been achieved using antibody-labeled magnetic NPs for sample pretreatment [39].
Multilayer NPs can perform several functions simultaneously. (Lv et al.) (2017) designed
RuSi@Ru(bpy)3(2+) loaded with gold-functioned nanoporous CO/Co3O4 electrochemiluminescence
biosensors for sensitivity (5 pg/mL) detection of DON [40]. Ag@Au Core-Shell NPs have been used
for surface-enhanced Raman scattering aptasensors for the double detection of OTA A and AFL B1.
Principally, Raman scattering aptasensors produce stable and quantitative signals that emerge from
the plasmonic coupling at the junction of a silver core and a gold shell [41]. The latest development
has focused on one-step multiplex detection of various mycotoxins. Whether in the form of a strip or
whatever form is needed for a device, this simplifies the whole analysis [42] (Figure 1b). Kong et al.
made semiquantitative and quantitative multi-immunochromatographic strips based on gold NPs as a
label for the detection of 20 mycotoxin. An advantage of this is the ability to read results by the naked
eye. The visual limits of detection for ZEAs, DONs, T2s, AFs, and FUMs were estimated to be 0.1–0.5,
2.5–250, 0.5–1, 0.25–1, and 2.5–10 µg/kg, respectively [43].
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Figure 1. Different immunodetection arrangements. (a) n electrosensor based on the interaction of
the antibody with mycotoxin, which amplifies the signal; (b) A lateral easy-to-use immunoassay for the
detection of mycotoxins by the naked eye. Figures adapted from [37,42], with permission from Elsevier
(2017) and John Wiley and Sons (2015), respectively.
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The abovementioned findings demonstrate the great potential of NPs for mycotoxin detection.
Therefore, detection requirements are greater than sensitivity and reliability. Mycotoxin derivates are
commonly undetectable by conventional analytical techniques due to their changed structure by plant
enzymes [44]. Enzymatic or acid hydrolysis is often employed prior to mycotoxin determination as an
effective pretreatment step of masked derivates [45]. Also, mass spectrometry could expose masked
mycotoxins [46–48]. The design of a proof of concept for the identification of unknown modified
masked mycotoxins is still a big challenge, which could be facilitated with NPs for both mycotoxin
isolation or detection.
3. Nano Approaches for Mycotoxin Risk Elimination
Recently, questions have been raised about the nanotechnology solution of mycotoxin risk.
There are three general strategies: mold inhibition, mycotoxin adsorption, and impact elimination.
3.1. Antifungal Nanomaterials Cause Mold Inhibition and Mycotoxin Production
The past decade has seen the rapid development of antibacterial nanoparticles as a solution for
antibiotic resistance of pathogenic bacteria. Their applicability against mycotoxin occurrence has
been limited by differences between bacteria and fungi. Bacteria are single celled, whereas most
fungi are multicellular; bacteria have three distinct shapes, while fungi have various shapes which
lead to mycelium formation; bacteria reproduce sexually, whereas fungi are capable of reproducing
both sexually or asexually. All these differences make fungi more durable and resistant against some
antibiotics [49]. Until now, research has tended to focus on antibacterial nanoparticles rather than
on nanoparticles against fungi. The latest findings in the field of antifungal nanoparticles have been
summarized between 2016 and 2017 [50–54]. In practice, the prevention of mycotoxin occurrence
could be mediated via antifungal nanoparticles, which are easy to produce in large scale. According
to recent scientific articles (summarized in Tables 1 and 2), the antifungal strategy is oriented in two
directions. Firstly, an antifungal compound is encapsulated into a polymeric nanocage. Perhaps the
most serious disadvantage of this method is the instability in air, although nanopolymers allow cargo
release under the appropriate conditions (e.g., presence of enzymes, higher temperature, pH change).
Secondly, inhibition effect is reached by nanoparticles alone. This method mainly relies on metal
nanoparticles which are stable, act immediately, and offer the possibility of green synthesis. Moreover,
the advantage of green synthesis is the formation nanobiocomposites using plant, micro-organism,
and animal sources which show less toxicity and improved their main features (Table 2) [55].
Table 1. Antifungal nanoparticles synthetized by the chemical route.
Organism Type of Particles Inhibition Dose Average Size Reference
Alternaria brassicicola Silver nanoparticles 100 ppm NA [56]
Alternaria solani Silver nanoparticles 10 ppm 14 nm [57]
Alternaria solani and
Sclerotium rolfsii PEGylated Mancozeb 3 mg/L NA [58]
Aspergillus flavus Thyme essential oils inchitosan-benzoic acid nanogel 300 mg/L 100 nm [59]
Aspergillus flavus Menthe piperita essential oils inchitosan-cinnamic acid nanogel 500 ppm 100 nm [60]
Aspergillus flavus Cuminum cyminum essential oilsin chitosan-caffeic acid nanogel 650 ppm 100 nm [61]
Aspergillus flavus Nanodispersed Cinnamaldehydeby surfactant (Tween 80) 1.0 mM 60 nm [62]
Aspergillus flavus Silver nanoparticles 5 µg/mL 4.5 nm [63]
Aspergillus flavus Titanium dioxide nanoparticles 1 g/L 30 nm [64]
Aspergillus niger Silver-, copper-, and nickel-basednanoparticles 65 µg/mL 15 nm [65]
Aspergillus niger Pullulan and silver nanoparticles 1.7 mg/g 9 nm [66]
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Table 1. Cont.
Organism Type of Particles Inhibition Dose Average Size Reference
Aspergillus parasiticus Citrate-coated silver nanoparticles 50 ng/mL 20 nm [67]
Aspergillus parasiticus Silver nanoparticles 180 µg/mL NA [68]
Fusarium culmorum Silver nanoparticles 20 mg/L 35 nm [69]
Fusarium graminearum Chitosan nanoparticles 5000 ppm 200 nm [70]
Fusarium oxysporum Chitosan silver nanocomposites 100 µg/mL 370 nm [71]
Fusarium oxysporium Alumina nanoparticles 400 mg/L 200 nm [72]
Fusarium solani Ag-doped Titan oxidenanoparticles 0.43 mg/plate NA [73]
Penicillium expansum
and Botrytis cinerea Zinc oxide nanoparticles 3 mmol/L 70 nm [74]
Penicillium digitatum
and Fusarium solani Copper nanoparticles 20 and 60 µg/mL NA [75]
Penicillium verrucosum Silica and silver nanoparticles 5–100 ppm 0.65 nm and200 nm [76]
Penicillium and Mucor Zinc oxide nanoparticles 5 mg/mL 600 nm [77]
Table 2. Antifungal green synthetized nanoparticles.
Organism Mediator Type of Particles Inhibition Dose Average Size Reference
Aspergillus sp. and
Rhizopus sp. Aloe vera leaf extract Ag 100 µL of 1 M 70 nm [78]
Aspergillus ochraceus Aspergillus terreus andPenicillium expansum Ag 3 and 9 g/100 mL 20 nm [79]
Aspergillus niger and
Aspergillus flavus Cissus quadrangularis CuO 1000 ppm 30 nm [80]
Aspergillus flavus Penicillium citrinum Ag 4000 ppm 54 nm [81]
Aspergillus fumigatus
and Candida albicans Bacillus species Se 100 µg/mL 140 nm [82]
Candida, Aspergillus,
and Fusarium Arthroderma fulvum Ag 1 mg/mL 15 nm [83]
Fusarium Chaetomium globosum Ag 500 mg/L 15 nm [84]
The relationship between an NP’s antifungal activity and mechanism of action has been investigated.
He et al. studied the influence of ZnO nanoparticles on Botrytis cinerea and Penicillium expansum. ZnO
NPs producing reactive oxide species (ROS) leads to the damage of the lipid bilayer cell membrane and
the breakdown of the affected cell [74]. Scanning electron microscopy (SEM) showed the formation of
unusual bulges on the surface of fungal hyphae and deformation of fungal hyphae after treatment with
12 mmol/L ZnO NPs. More recent attention has been focused on silver nanoparticles. The findings
indicate that Ag NPs inhibit fungal growth as well as morphological and metabolic changes [85,86].
For instance, the application of 45 ppm Ag NPs caused a decrease of organic acid (oxalic, maleic,
and citric acid) production, mycotoxin production (up to 80%), and changes in the enzymatic profile
in Aspergillus niger and Penicillium chrysogenum [85]. All the studies reviewed so far, however, suffer
from the fact that the interaction of NPs with the individual components of the fungi cells has not been
investigated yet.
3.2. Nanoparticles Suitable for Mycotoxin Adsorption
The high expectations of using nanomaterials as special adsorbents to remove pollutants
relies not only on the high surface area and the high affinity to organic compounds (properties
of conventional adsorbents such as those possessed by activated carbon) but also greatly on the
fact that nanomaterials can be engineered or modified specifically to enhance selectivity to specific
target pollutants [87]. Mycotoxins show a structural diversity resulting in different chemical and
physical properties. Mycotoxins can be classified as polar or nonpolar molecules; however, there
are several that fall in between. AFLs and FUMs are highly polar, while trichothecenes are polar
and ZEAs are nonpolar [88,89]. This diversity could be resolved by such a material that changes
its properties under various physicochemical conditions and can denote both polar and nonpolar
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substances [87]. The following subsections describe the most promising nanomaterials for the
elimination of mycotoxins.
Carbon Nanostructures
Activated charcoal has been used for mycotoxin elimination for a long time. From this
established practice proceeds the use of carbon nanoforms as a promising successor to activated
carbon. The advantages of carbon nanomaterials are excellent stability, inertness, high adsorptive
properties, large surface area per weight, and colloidal stability upon various pHs, which is important
to preserve in the gastrointestinal tract [90]. Chemically, the carbon–carbon covalent bonds and
crystalline structure provide specific properties such as strength, elasticity, and great conductivity.
Graphene, graphene oxide, nanodiamonds, fullerenes, fiber, and nanotubes have a great potential to
become novel adsorbents of mycotoxins. Nanocarbon structures are amphoteric and their surface could
be protonated or deprotonated, which results in the binding capacity of polar or nonpolar compounds.
Binding activity properties of carbon nanomaterials are summarized in Figure 2. Generally, carbon
nanotube adsorption affinity poorly correlates with hydrophobicity but increases in the order of
nonpolar aliphatic < nonpolar aromatics < nitroaromatics functional groups [91].Na omaterials 2018, 8, x FOR PEER REVIEW  7 of 21 
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Fullerene adsorption behavior was found to be higher than that of activated carbon. Preliminary
investigations of fullerenol C60(OH)24 nanoparticles on mycelial growth, aflatoxin production,
and oxidative stress modulation in an aflatoxigenic strain of Aspergillus flavus showed slightly reduced
mycelial biomass weight but significantly decreased aflatoxin concentration in media. A concentration
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10 ng/mL of fullerenol reduced aflatoxin production compared to a control sample [92]. The possible
mechanism could be explained by oxidative stress suppression of fungal culture [93].
Nanodiamonds show all the benefits of carbon nanomaterials and their large-scale production
is considered to be inexpensive. Their chemical structure allows surface functionalization, including
carboxylation, hydrogenation, and hydroxylation, which could provide binding affinity to various
types of the mycotoxins. Nanodiamond aggregates (~40 nm) tend to adsorb AFL B1 and
OTA via electrostatic interactions that depend on the types functional groups on the surface of
nanodiamonds [94]. The adsorption capacity was estimated for AFL B1 as approximately 10 µg per mg
of nanodiamonds and for OTA around 15 µg per mg of nanodiamonds. These results indicate greater
adsorption capacities than commercially used yeast cell walls and clay minerals [95].
The perspective of single/multiwalled carbon nanotubes (CNT) should also be mentioned at
this point. To date, CNTs are experimentally used for various medicinal applications such as drug
administration, target therapy, or diagnostics in humans. In vivo experiments on mouse models
indicated the absence of a pronounced toxic effect under conditions of a short-term experiment.
On contrary, nanotubes affected mouse gastrointestinal mucosa and induced a weak immune
response based on CNT modification and functionalization [96,97]. Nevertheless, their good
adsorption capacity is well utilized in solid phase extraction protocols mainly for zearalenone [98–100],
trichothecenes [101–103], and aflatoxins [104].
Magnetic graphene (MGO) synthesized from iron oxide nanostructures and graphene oxide is
inexpensive and easily accessible. Numerous oxygen functional group on the MGO surface enable
interaction with fusarium mycotoxins (DON, T1, and T2). An adsorption procedure was performed
by dissolving palm kernel cake in water (6.2 pH for 5.2 h at 40.6 ◦C) and subsequently MGO with
bounded mycotoxins was removed via magnet. Results showed that the reduction of mycotoxins
varied from 40% to 70% for T2 and DON, respectively [105]. Surface active maghemite nanoparticles
(SAMN) constituted of stoichiometric maghemite (γ-Fe2O3) showed chelating properties for citrinin
and OTA toward iron(III) presence [106]. Monascus suspensions were treated with 1 gL−1 SAMNs,
leading to 70% citrinin removal for the first time. A second treatment removed citrinin below the
analytical detection limits (0.25 mg L−1). SAMNs represent an ideal material, as their synthetic protocol
is suitable for being scaled up to an industrial level and is carried out in water without using of any
organic solvent [106].
Chitosan Polymeric Nanoparticles
Chitosan (CS) is a natural cationic polysaccharide produced from chitin, which is the structural
element found in the exoskeleton of crustaceans. In contrast to similar polysaccharide celluloses, CS
contains hydroxyl groups, acetylamine, or free amino groups which has attracted attention in many
fields of applications. CS is nontoxic, biodegradable, and possesses low immunogenicity. Therefore,
CS has shown promising results for mycotoxin elimination from different raw materials. In 1990s,
CS began to be considered as a suitable mycotoxin adsorbent with approximately 70% efficacy [107].
In addition, a CS solution in a mixture with the minerals rektorit and attapulgit has been patented for
removing feed zearalenone and reducing diarrhea due to its antimicrobial properties [108].
Although carbon nanostructures are the focus of much research nowadays, chitosan polymer and
nanoparticles have been highlighted in the years 2010–2015. CS is easily subjected to nanoparticles via
the gelatation process using aldehydes (e.g., glutaraldehyde) and acids (e.g., thioglycolic, acrylic,
and oxalic acids) [109]. Another way for nanoparticle formation is ionic cross links based on
electrostatic interaction with phosphoric acid derivatives such as sodium tripolyphosphate (TPP) [110].
Chitosan’s ability to quickly gel relies on the formation of inter- and intramolecular cross linkages
between TPP phosphates and chitosan amino groups. The properties of prepared CS nanoparticles
depends on physicochemical conditions such as pH, temperature, time, and functionalization or
modification by specific ligands [111,112].
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It is widely known that CS NPs are able to encapsulate various compounds. Glutaraldehyde
crosslinked chitosan showed promising adsorption ability for AFL B1 (73%), OTA (97%), ZEN (94%),
and FUM 1 (99%) but no obvious adsorption for DON and T2 (<30%) in a buffer system simulating
gastrointestinal conditions [113]. Although having great binding capacity, glutaraldehyde is considered
to be toxic. LD50 for rats has been determined to be 1.30 mL 50% a.i./kg body wt. On the other hand,
TPP is a nontoxic, anionic chelating agent forming stable CS NPs. Using a water-in-oil microemulsion
encapsulation method, magnetic Fe3O4 CS NPs were synthetized as patulin adsorbents with high
magnetic properties, adsorption capabilities, and hypotoxicity. Patulin molecules were adsorbed
completely after 5 h with an adsorbent concentration of 400 µg in conditions mimicking the pH of
juice. In vitro cytotoxicity and acute toxicity tests showed negligible cytotoxicity, no toxic response,
or histopathology in treated mice [114].
Nanoclay Binders
This group includes minerals that are used for the detoxification of mycotoxins from food and
feed, such as montmorillonite, bentonite, zeolite, or hydrated sodium (calcium) aluminosilicate.
Their specificity is the willingness to form multiphase solid materials where one of the phases has one,
two, or three dimensions of less than 100 nm, e.g., montmorillonite. Montmorillonite nanocomposite
(MN) has been introduced as a perspective sorptive additive possessing sizable surface area, higher
porosity, strong cation exchange activities, and more active sites, which enable its interaction with
mycotoxins [115]. The in vitro obtained adsorption capacity of MN for AFL was estimated to be
66.67 µg/mg MN. In vivo testing in broilers demonstrated no toxic effect with a 3 g/kg diet [116].
Moreover, MN addition increased super oxide dismutase and glutathione peroxidase activities and
simultaneously reduced malondialdehyde levels. Modified nanomontmorillonite by organic cations
(cetyltrimethylammoniumbromide) increased the hydrophobicity of the surface of the mineral and
showed a high affinity for AFLs, ZEA, and FUM B1 adsorption in rat models in vitro [117].
Unlike nanocomposites, halloysite (Al2Si2O5(OH)4) naturally occurs as a small cylinder
(nanotubes) that has a wall thickness of 10–15 atomic alumosilicate sheets, an outer diameter of
50–60 nm, an inner diameter of 12–15 nm, and a length of 0.5–10 µm [118]. Its outer surface is
mostly composed of SiO2 and the inner surface of Al2O3, and, hence, those surfaces are oppositely
charged [119]. The external siloxane and internal aluminol surface of halloysite is efficient as an
absorbent (described above) or could be used as a carrier for drugs [120–123], nucleic acids [124],
antibacterial agents [125], and antioxidants [119,126–130]. Therefore, halloysite is an efficient adsorbent
both for cations and anions. Moreover, halloysite nanotubes could be modified by various surfactants to
enhance their sorption properties and specificity [131]. For instance, stearyldimethylbenzylammonium
chloride has been shown to improve protection efficacy against the detrimental effects of ZEN
exposure [132]. The ZEN sorption properties in vitro by modified halloysite nanotubes were
investigated from simulated gastric fluid and simulated intestinal fluid. Adsorption efficiency for ZEN
was estimated to be 1 mg/mL after 120 min. The results indicated mitigated toxic and estrogenic effects
of ZEN, including changes in oxidative stress biomarkers and organ weights in rat animal model [133].
Promising results have been published in another study that focused on a comparison of ZEN toxicity
with and without halloysite addition and its impact on swine kidney. ZEN treatment significantly
increased biochemical parameters, inflammatory cytokines, and degenerative changes in the kidney
and induced oxidative damage in plasma. Moreover, the addition of halloysite in combination with
ZEN induced a re-establishment of biochemical parameters, plasma oxidative stress enzyme activities,
and the normal histology of the kidney [134]. An implication of this is the possibility that halloysite
is a prospective mycotoxin adsorbent due to its safety for micro-organisms, worms, fish, and small
animals [135,136].
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Prospective Use as Antibodies
Nanomaterials are not only promising sorbents but are also able to couple different molecules
such as antibodies or targeting peptides. The application of antibodies has been highly developed
in the field of medicine and target drug therapy [137,138]. Briefly, there are three ways of antibody
conjugation on the surface of NPs: by adsorption, by direct covalent linkage between the surface
of the NP and the antibody, or by using adapter molecules such as streptavidin and biotin. Direct
coupling via adsorption requires specific surface properties which allow the interaction with antibody.
Preferably, covalent attachment of the antibody allows interaction with antigen binding sites. For this
purpose, carboxylic acids, which is the most common group present on NP surfaces (especially carbon
nanostructures), could be employed for reaction with ligands. The prerequisite for effective antibody
binding is the production of a stable association, a controlled amount of immobilized antibody, and the
preservation of antibody activity [139–142].
In recent years, there has been increasing interest in sample pretreatment using
antibody-decorated magnetic nanoparticles. This technique would facilitate purification by magnetism
and combine a high capacity for purification with fast dispersibility due to the small size of the particles.
It was estimated that during a 5-min purification step, an average of 80% of the ZEN and AFL B 1
returns from mycotoxin-contaminated feed mixture (10–50 ng/mL) was achieved [143]. Nanobodies
(Nb) are derived from heavy chains of antibodies. Magnetic beads carrying poly (acrylic acid)
brushes (MB@PAA) were fabricated as an “Nb container” for improving AFL B1 adsorption capacity.
The achieved binding capacity of 0.23 mg·g−1 was reached [144]. In the case of magnetic separation
of mycotoxins, there is no need to restrict this to chemically synthetized nanoparticles, as natural
maghemite nanoclusters produced by magnetotactic bacteria can be employed with satisfactory
results [145,146]. On the surface of magnetosomes, antimycotoxin antibodies can be easily attached as
well as on chemically synthetized nanoparticle [147]. Future research should therefore concentrate on
the investigation of the biological synthesis of nanoparticles for magnetic separation of mycotoxins
from food and feed.
3.3. Nanomaterials that Impact Mycotoxin Elimination from Affected Organisms
Previous studies have reported that actual exposure to mycotoxins leads to higher oxidative stress
in organisms [148,149]. Because an effective antidote does not exist, nutritional supplements could
suppress the toxic impact of mycotoxin, decrease tissue damage caused by oxidative stress, and allow
the body to sustain a viable immune system that can eradicate the pathogen. For instance, higher doses
of natural antioxidants such as tocopherol, selenium, or zinc are recommended in animal feed [150,151].
In recent years, it was found that cerium, zinc (titanium) oxide, silver, gold, selenium, or carbon-based
nanoparticles show unique antioxidant properties [152–154]. Moreover, better antioxidant properties
of metal nanoparticles could be reached by green synthesis. It is well known that green-synthetized
nanoparticles are enriched with natural compounds, which leads to their better donor activity [155].
Although their effectiveness against mycotoxin intoxication has been not explored yet, their beneficial
impact on organisms should be assumed.
Polymeric nanocapsules are able to protect and deliver antioxidants to the target tissue. Ideally,
the compound is transported to the target site where it is gradually released from the transporter.
The protective role of chitosan nanoparticles singly, plus quercetin (Q) at low (140 mg/kg b.w.) or high
(280 mg/kg b.w.) doses, was investigated against OTA-induced toxicity on mice. Q is a member of
the flavonoids family and it is well known that Q has wide bioactivity, including hypolipidemic and
antioxidant properties. Previous studies have reported that Q showed a protective effect against the
toxic effect of mycotoxins such as aflatoxin [156,157], OTA [158–160], T2 [161], zearalenone [162,163],
and alternariol [164]. Round-shaped nanoparticles consisting of quercetin showed a protective effect on
OTA-treated rats (3 mg/kg diet). CS-NPs/Q-supplemented animals showed significant improvements
in food intake, body weight gain, serum biochemical parameters, histological picture and histochemical
analyses, antioxidant enzymes such as glutathione peroxidase (GPx), super-oxide dismutase (SOD)
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and catalase (CAT) and malondialdehyde (MDA), DNA fragmentation, and gene expression due to
minimal changes in serum biochemical parameters in comparison with untreated mice models [165].
Combined treatment with Q and CS NPs enhanced the ability to donate Q protons. Figure 3 presents a
possible mechanism of action of Q-loaded CS nanoparticles via the Keap1-Nrf2 pathway (200 nm).Nanomaterials 2018, 8, x FOR PEER REVIEW  10 of 21 
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Figure 3. Scheme of the quercetin (Q)-loaded chitosan (CS) nanoparticle mechanism of action.
The relaxed polysaccharide structure of the chitosan is crosslinked with tripolyphosphate (TPP).
The Q is entrapped in the CS structure. The positive charge of NPs electrostatically interacts with
the negatively charged epithelial cell wall. Quercetin triggers a hepato-protective cascade that
leads to antioxidant protection via stimulation of nuclear factor E2-related factor 2 (Nrf2)-induced
heme-oxygenase-1 (HO-1) production. Transcriptional response is mediated by the acting element
termed (ARE) found in the promoters of genes encoding the detoxication enzymes. Q-inhibited
lipopolysacharide (LPS) induced nitric oxide synthase (iNOS) and NO production via IκB kinase (IKK)
and p38 mitogen-activated protein kinases (p38MAPK). The proposed mechanism of action of quercetin
is adapted from [166], with permission from Public Library of Science, 2015.
4. Efficiency Evaluation of Nanoparticles as a Solution for Eliminating the Risk of Mycotoxins
The issue of nanomaterials has received considerable critical attention regarding their toxicity on
the living organisms. In addition, the massive increase of nanotechnology in many applications has
caused the emergence of an opposing discipline (nanotoxicology). It could be assumed that newly
synthetized nanoparticles are immediately examined for their toxicity and applicability. Nanotoxicity
depends on particle solubility, surface area, number of particles per volume, surface charge, size,
and tendency to agglomerate, which determine the elimination nanoparticles from the body [167].
The mentioned properties indicate the mechanism of action. Among those that have been described are
the interaction with cell membrane, apoptosis induction, ROS production, inhibition of mitochondrial
functions, lipid peroxidation, or autophagy [168]. Experimental studies have proven that nanoparticles
could act as oxidative stress inductors, cytotoxically, as inflammatory agents, or could interact with
nucleic acids and thereby contribute to the damage of both microorganisms and higher plants and
humans [169]. Current toxicologic studies have found that the most organism-friendly are cerium
oxide nanoparticles, fullerenes, or polymeric nanoparticles (Polyethylenglycol or chitosan). On the
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other hand, many inorganic nanoparticles have been considered as hazardous [170]. An objective
assessment of toxicity seems to be difficult. A number of publications have been created on this topic
and consortia and research groups have emerged as well. So, the status of this issue is still evolving.
Interestingly, particle toxicity often works differently on model stem cells and organs. Furthermore,
viability tests, such as the MTT assay, are sensitive to pH and medium, as found Jo et al. [171].
The relationship between the dose and the response of the organism must be taken into account
as well as the accumulation in the environment and the chronic exposure of the organism to low
doses [172–174].
In terms of efficiency evaluation, the toxicity of antimycotoxin nanomaterials and the toxic effect
of mycotoxins have to be carefully considered. A key problem with nanomaterial efficiency against
mycotoxin evaluation is the uncomplicated studies that are unilaterally focused. In reviewing the
literature, no relevant data was found on the association between nanomaterial effectivity, toxicity,
and the received dose of mycotoxins from food and feed. There are predominantly studies that focus
on nanoparticle synthesis. Large-scale production has been improved by the fact that the prices
of nanoparticles (listed in Table 3) are comparable to those of commonly used bentonite for the
elimination mycotoxins from feed (2–8 USD per gram in the Czech Republic). Therefore, our intention
was to outline the relationship between the threat of concentration of mycotoxins taken from food
and the effectiveness of nanoparticles to eliminate them (Table 3). Nanoparticle efficiency against
mycotoxins (AFL, OTA) vary from 0.065 to 1000 µg/mg depending on the nanomaterial used (magnetic
graphene oxide < maghemite and halloysite nanoparticles < nanodiamonds < montmorillonite
nanocomposite < chitosan nanoparticles). The scientific literature shows the toxic effect of the most
common mycotoxins to be in the range of 1–30 mg/kg of the feed dose [175]. Theoretically, only 30 mg
of nanoparticles per 1 kg of compound feed is sufficient to eliminate the toxic effect. In the case of the
toxicity of selected nanoparticles, we have found from the literature that the safe level for mice is on
average 0.3–16,000 mg/kg. Taken together, the results of nanoadsorbent efficiency against mycotoxins
would have been far more persuasive if the authors had considered the actual practical feed dose
of mycotoxins.
Table 3. Binding capacity and dose evaluated as safe in mouse models for selected
mycotoxin nanoadsorbents.
Nanostructure Preparation Method Ref. USD/g
Dose Evaluated
as a Safe in
Mouse Models
Ref. Mycotoxin BindingCapacity Ref.
Nanodiamonds
ion and laser bombarding, CVD,
hydrothermal, ultrasonic,
electrochemical








impregnating graphene oxide with
magnetic nanoparticles









decomposition of organic precursors
at high temperatures, oxidation of
magnetite nanoparticles







[182] 1–5 16,000 mg/kg [183]
AFL 0.8 µg/mg
[116]
ZEA, OTA 1 µg/mg
Montmorillonite
nanocomposite
hot intercalation technique, in situ
polymerization, solution induced
intercalation 10, melt processing
[184] 1–5 1000 mg/kg [185] AFL 67 µg/mg [119]
Modified
halloysite nanotubes naturally occuring [121] <1 10 mg/mL [119] ZEA 1000 µg/mg [136]
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5. Conclusions
In this review, we summarized the current findings of mycotoxins and their elimination by
nanoparticles. Many researchers see the application potential of nanomaterials in the field of biosensors
for mycotoxin detection rather than elimination. Although the exceptional properties of nanomaterials
have obliged the development of this field of knowledge, the combination of knowledge of disciplines
from toxicology, nanotechnology, and agricultural practices is on the rise. These findings further
support the idea of the one nanoparticle which could be employed for mycotoxin detection as well
as elimination and could serve as a nanocage for nutrition delivery. Further research should be done
to investigate the detailed toxicity and efficiency testing as is also required in other nanotechnology
disciplines. The conclusion of this review suggests that nanomaterials have interesting adsorption
properties, which make them promising for mycotoxin elimination.
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